Newly Diagnosed Archives

September 1, 2022

ASH 2021: Dr. Brian Koffman on Awareness, Knowledge, and Preferences of Patients with Chronic Lymphocytic Leukemia (CLL) and Their Caregivers Related to Finite Duration Therapy and Measurable Residual Disease

At the American Society of Hematology (ASH) 2021, Dr. Sameer Parikh, a hematologist and oncologist at the Mayo Clinic in Rochester, MN, interviewed our own Dr. Brian Koffman, Executive Vice President and Chief Medical Officer of the CLL Society. They discussed results from a survey of patients and caregivers.

August 25, 2022

ASCO 2022: Incidence, Predictors, and Outcomes of Cardiovascular Events in Patients with Chronic Lymphocytic Leukemia

CLL patients are at higher risk for several types of cardiac events and have higher rates of in-hospital mortality, regardless of why they were admitted. In addition, this trial was seriously flawed as it did not address what CLL treatments were used. We know certain therapies such as BTKi,

August 8, 2022

Chronic Lymphocytic Leukemia: 2022 Update on Diagnostic and Therapeutic Procedures

CLL care changes fast. Doctors Hallek and Al-Sawaf are among the best to take on the task of documenting the latest as of October 2021 in this lengthy encyclopedic overview full of solid data and historical references. It was published for physicians in the American Journal of Hematology, not for

July 27, 2022

Q&A with Dr. Josh Hill on Monkeypox

In this interview, our own Dr. Brian Koffman spoke with Dr. Joshua Hill, an infectious disease specialist at the Fred Hutchinson Cancer Center in Seattle, WA, about monkeypox and the current outbreak. Dr. Hill specializes in the infectious disease care of cancer and other immunocompromised patients.

July 13, 2022

ASH 2021: Dr. Deborah Stephens on Early Intervention vs. Delayed Therapy with Venetoclax plus Obinutuzumab for Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

We discussed an ongoing clinical trial currently recruiting patients to see if early intervention with venetoclax plus obinutuzumab can produce better outcomes for high-risk patients compared with traditional delayed therapy.

June 23, 2022

The CLL Nurse’s Note: Understanding the Importance of Screening for Skin Cancer While Living with CLL/SLL

Recently, several questions have come into CLL Society from patients who were not aware that CLL/SLL also carries a higher risk of developing secondary cancers, particularly skin cancer.

May 12, 2022

An Immunologist Reviews CLL/SLL Patients and Their Compromised Immunity

We discussed the nature of the immune deficiencies associated with CLL/SLL and how one might remediate a significant part of the problem.

May 6, 2022

ASH 2021: Age-Related Differences in the Informational Experiences and Needs of Patients with Lymphoma: Results from the 2020 Lymphoma Coalition Global Patient Survey

In this study presented at the American Society of Hematology Annual Meeting and Exhibition (ASH 2021), the authors compared the experience in 5 different age groups on the amount of information provided, how well the information was understood, and topics on which patients and caregivers needed more information.

March 21, 2022

Vaccinations for Patients with CLL/SLL

This article aims to help provide guidance because knowing which vaccinations to get can be confusing. This article will lay out the current United States national vaccines recommendations to help you make the proper choices.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Newly Diagnosed

ASH 2021: Dr. Brian Koffman on Awareness, Knowledge, and Preferences of Patients with Chronic Lymphocytic Leukemia (CLL) and Their Caregivers Related to Finite Duration Therapy and Measurable Residual Disease

ASCO 2022: Incidence, Predictors, and Outcomes of Cardiovascular Events in Patients with Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia: 2022 Update on Diagnostic and Therapeutic Procedures

Q&A with Dr. Josh Hill on Monkeypox

ASH 2021: Dr. Deborah Stephens on Early Intervention vs. Delayed Therapy with Venetoclax plus Obinutuzumab for Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

The CLL Nurse’s Note: Understanding the Importance of Screening for Skin Cancer While Living with CLL/SLL

An Immunologist Reviews CLL/SLL Patients and Their Compromised Immunity

ASH 2021: Age-Related Differences in the Informational Experiences and Needs of Patients with Lymphoma: Results from the 2020 Lymphoma Coalition Global Patient Survey

Vaccinations for Patients with CLL/SLL

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT